Edwards Lifesciences Corporation Common Stock (EW): Acquisition News

EW – Acquired privately held medical tech company Harpoon Medical for $100 mln cash at closing (potential for up to $150 mln in pre-specified milestone-driven payments over the next 10 years).


Key Facts Surrounding This News Item


  • EW had a POWR Rating of A (Strong Buy) coming into today.
  • EW was 0.26% above its 10-Day Moving Average coming into today.
  • EW was 3.59% above its 20-Day Moving Average coming into today.
  • EW was 4.17% above its 50-Day Moving Average coming into today.
  • EW was 1.51% above its 100-Day Moving Average coming into today.
  • EW was 4.13% above its 200-Day Moving Average coming into today.
  • EW had returned +20.65% year-to-date leading up to today’s news, versus a +19.42% return from the benchmark S&P 500 during the same period.

More Info About Edwards Lifesciences Corporation Common Stock (EW)


Edwards Lifesciences provides products and technologies to treat structural heart disease and critically ill patients worldwide. It is a manufacturer of heart valve systems and repair products used to replace or repair a patient’s diseased or defective heart valve. The company was founded in 1999 and is based in Irvine, California. View our full EW ticker page with ratings, news, and more.

EW at a Glance

EW Current POWR Rating™
Overall POWR Rating™
EW Current Price $115.57 2.21%
More EW Ratings, Data, and News

EW Price Reaction

The day of this event (Dec. 6, 2017)
EW Closing Price$113.36 0.27%
EW Volume1,530,300
10.39% from avg
Leading up to this event
EW 1-mo return9.59%
After this event
EW 1-day return3.75%
EW 3-day return4.34%

EW Price Chart



More Edwards Lifesciences Corporation Common Stock (EW) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All EW News
Page generated in 0.7798 seconds.